Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA briefly suspended the ability of an independent IRB to conduct expedited reviews after raising concerns over the conduct of one such review.

FDA briefly suspends IRB's ability to do expedited reviews